Lupin has forayed into over-the-counter (OTC) segment in the country and plans to achieve Rs.300 crore turnover in the vertical in the next 5 years....
Lupin has received US health regulator’s approval for generic Tamiflu Capsules. The company stated that, it has received final approval for its Oseltamivir Phosphate Capsules...
EquityPandit’s Outlook for Lupin for the week ( Jan 08, 2018 – Jan 12, 2018) : LUPIN: Lupin closed the week on positive note gaining around 1.70%. As...
Lupin for treating serious infections has launched Flucytosine capsules, in the American market. In a regulatory filing, Lupin stated that, the company has launched its...